Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0342 Transporter Info
Gene Name	SLC39A14
Transporter Name	Zinc transporter ZIP14
Gene ID	23516
UniProt ID	Q15043

Post-Translational Modification of This DT
Overview of SLC39A14 Modification Sites with Functional and Structural Information
Sequence	M K L L L L H P A F Q S C L L L T L L G L W R T T P E A H A S S L G A P A I S A A S F L Q D L I H R Y G E G D S L T L Q Q L K A L L N H L D V G V G R G N V T Q H V Q G H R N L S T C F S S G D L F T A H N F S E Q S R I G S S E L Q E F C P T I L Q Q L D S R A C T S E N Q E N E E N E Q T E E G R P S A V E V W G Y G L L C V T V I S L C S L L G A S V V P F M K K T F Y K R L L L Y F I A L A I G T L Y S N A L F Q L I P E A F G F N P L E D Y Y V S K S A V V F G G F Y L F F F T E K I L K I L L K Q K N E H H H G H S H Y A S E S L P S K K D Q E E G V M E K L Q N G D L D H M I P Q H C S S E L D G K A P M V D E K V I V G S L S V Q D L Q A S Q S A C Y W L K G V R Y S D I G T L A W M I T L S D G L H N F I D G L A I G A S F T V S V F Q G I S T S V A I L C E E F P H E L G D F V I L L N A G M S I Q Q A L F F N F L S A C C C Y L G L A F G I L A G S H F S A N W I F A L A G G M F L Y I S L A D M F P E M N E V C Q E D E R K G S I L I P F I I Q N L G L L T G F T I M V V L T M Y S G Q I Q I G
PTM type	X-Acetylation X-N-glycosylation X-Phosphorylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A14			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	326
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC39A14 Lysine 326 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Critically important for determining membrane extraction and the iron sensitivity of SLC39A14			[2]
Role of PTM	On/Off Switch
Modified Residue	Asparagine	Modified Location	102
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Glycosylation at SLC39A14 Asparagine 102 have been reported to be critically important for determining its membrane extraction and the iron sensitivity.
PTM Phenomenon 2	Have the potential to influence SLC39A14			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	77
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC39A14 Asparagine 77 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC39A14			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	87
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC39A14 Asparagine 87 has the potential to affect its expression or activity.
Phosphorylation
Serine	10 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A14			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	256
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 256 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC39A14			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	260
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 260 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC39A14			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 262 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC39A14			[3] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	265
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 265 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC39A14			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	291
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 291 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC39A14			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	292
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 292 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC39A14			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	309
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 309 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC39A14			[11] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	311
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 311 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC39A14			[11] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	318
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 318 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC39A14			[11] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	320
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Serine 320 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A14			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	258
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC39A14 Tyrosine 258 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A14			[15]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	322
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC39A14 Cystine 322 has the potential to affect its expression or activity.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC39A14			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	63
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC39A14 Lysine 63 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC39A14			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	267
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC39A14 Lysine 267 has the potential to affect its expression or activity.

References
1	Regulation of cellular metabolism by protein lysine acetylation. Science. 2010 Feb 19;327(5968):1000-4.
2	An iron-regulated and glycosylation-dependent proteasomal degradation pathway for the plasma membrane metal transporter ZIP14. Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9175-80.
3	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
5	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
6	Integrated analysis of global proteome, phosphoproteome, and glycoproteome enables complementary interpretation of disease-related protein networks. Sci Rep. 2015 Dec 11;5:18189.
7	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
8	Identification of Mediator Kinase Substrates in Human Cells using Cortistatin A and Quantitative Phosphoproteomics. Cell Rep. 2016 Apr 12;15(2):436-50.
9	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
10	Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
11	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
12	Highly reproducible improved label-free quantitative analysis of cellular phosphoproteome by optimization of LC-MS/MS gradient and analytical column construction. J Proteomics. 2017 Aug 8;165:69-74.
13	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
14	Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants. Elife. 2016 Sep 30;5:e18296.
15	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
16	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence